EUVIMEDPoznaj EUVIMED
Crossref

ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS

Harshveer Singh Jaitawat, Dr. C.S. Sharma, Dr. H.S. Udawat, Dr. P.S. Naruka

EPRA International Journal of Research & Development (IJRD) · 2026-08-17 · 91

DOI: 10.36713/epra28874 ↗

At a glance

Journal article in EPRA International Journal of Research & Development (IJRD), published online on 2026-08-17. Written by Harshveer Singh Jaitawat and 3 co-authors.

AbstraktDane bibliograficzneCiteRelated studies

Abstract (original language)

Background

Artificial intelligence-assisted drug discovery can reduce the chemical search space by integrating molecular generation, drug-likeness assessment and structure-based docking. However, computational rankings require careful validation and should be interpreted as prioritization rather than evidence of therapeutic efficacy.

Objectives

To integrate AI-assisted molecular design, physicochemical/ADMET screening, molecular docking and ligand–protein interaction analysis for identification of potential leads across selected cancer, metabolic and neurodegenerative targets.

Methods

A documented computational workflow was applied to five ligand-bound human targets—EGFR (1M17), KRAS G12C (5V71), DPP-4 (1X70), PTP1B (1C83) and AChE (4EY7). The supplied thesis dataset described progressive filtering of a 1350-member virtual library to 14 final candidates, followed by drug-likeness/ADMET assessment, AutoDock Vina docking and redocking validation. Candidate prioritization integrated docking score, target-relevant interactions and computational pharmacokinetic/toxicity characteristics.

Results

All five reference systems passed the predefined redocking criterion of

Cite

APA

Jaitawat, H. S., Sharma, D. C., Udawat, D. H., & Naruka, D. P. (2026). ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS. EPRA International Journal of Research & Development (IJRD), 91. https://doi.org/10.36713/epra28874

Vancouver

Jaitawat HS, Sharma DC, Udawat DH, Naruka DP. ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS. EPRA International Journal of Research & Development (IJRD). 2026:91. doi:10.36713/epra28874

BibTeX
@article{Jaitawat2026,
  author = {Jaitawat, Harshveer Singh and Sharma, Dr. C.S. and Udawat, Dr. H.S. and Naruka, Dr. P.S.},
  title = {ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS},
  journal = {EPRA International Journal of Research & Development (IJRD)},
  year = {2026},
  pages = {91},
  doi = {10.36713/epra28874}
}
Start for free →